In order to bring you the best possible user experience, this site uses Javascript. If you are seeing this message, it is likely that the Javascript option in your browser is disabled. For optimal viewing of this site, please ensure that Javascript is enabled for your browser.
Associate Professor Jurrien M ten Berg
Speaker
Associate Professor Jurrien M ten Berg

St Antonius Hospital, Nieuwegein (Netherlands (The))

Specialities : Acute Coronary Syndromes , Interventional Cardiology, Pharmacology and Pharmacotherapy, Valvular Heart Disease

16 presentations from this speaker

Alcohol septal ablation of hypertrophic cardiomyopathy - Introduction.

Congress : ESC Congress 2019

  • Session : Alcohol septal ablation of hypertrophic cardiomyopathy
  • Speaker : J ten Berg (Nieuwegein,NL)

Antithrombotic therapy post-PCI: practical tips for challenging scenarios

Congress : ESC Congress 2019

  • Session : NOACs in patients undergoing cardiac procedures
  • Speaker : J ten Berg (Nieuwegein,NL)
  • Sponsored by Boehringer Ingelheim

Optimal antithrombotic treatment after acute coronary syndromes.

Congress : ESC Congress 2019

  • Session : Expert Advice - Best practice in acute coronary syndromes
  • Speaker : J ten Berg (Nieuwegein,NL)

Bringing order to complexity: antithrombotic regimens for atrial fibrillation patients who underwent PCI.

Congress : ESC Congress 2018

  • Session : Bringing order to complexity: antithrombotic regimens for atrial fibrillation patients who underwent percutaneous coronary intervention
  • Speaker : C Cannon (Boston,US), J ten Berg (Nieuwegein,NL)
  • Sponsored by Boehringer Ingelheim

Optimal antithrombotic treatment in the first year post PCI for ACS

Congress : ESC Congress 2018

  • Session : Expert Advice - Antithrombotic therapy after acute coronary syndromes
  • Speaker : J ten Berg (Nieuwegein,NL)

Rational to remove aspirin from the cocktail. The story after WOEST...(VIA ZOOM)

Congress : Acute Cardiovascular Care 2018

  • Session : Anti-thrombotics in patients at simultaneous risk of stroke and stent thrombosis
  • Speaker : J ten Berg (Nieuwegein,NL)

Risky scores in acute coronary syndromes?

Congress : ESC Congress 2018

  • Session : The value of risk scores for assessment in acute coronary syndrome
  • Speaker : J ten Berg (Nieuwegein,NL)

How to manage ACS patients who require oral anticoagulation?

Congress : ESC Congress 2017

  • Session : Starting, stopping, and everything in between: recent data concerning dual antiplatelet therapy in ACS
  • Speaker : J ten Berg (Nieuwegein,NL)

General rules to minimise the risk of bleeding

Congress : ESC Congress 2016

  • Session : Acute coronary syndromes in the very elderly
  • Speaker : J ten Berg (Nieuwegein,NL)

Aspirin needs an antithrombotic companion and rivaroxaban should be added as soon as possible.

Congress : ESC Congress 2015

  • Session : Which is the best partner for aspirin in treatment of acute coronary syndromes?
  • Speaker : J ten Berg (Nieuwegein,NL)

How to manage triple therapy after stenting.

Congress : ESC Congress 2015

  • Session : Early morning an acute coronary syndrome patient comes in! How to manage?
  • Speaker : J ten Berg (Nieuwegein,NL)

Challenges and evidence.

Congress : ESC Congress 2014

  • Session : Warfarin or new anticoagulants in atrial fibrillation patients undergoing PCI
  • Speaker : J ten Berg (Nieuwegein,NL)

My patient with atrial fibrillation presents with acute coronary syndrome and needs a stent.

Congress : ESC Congress 2014

  • Session : Practical aspects on stroke prevention in atrial fibrillation
  • Speaker : J ten Berg (Nieuwegein,NL)

Optimal duration of dual antiplatelet therapy.

Congress : ESC Congress 2013

  • Session : What is new in stent thrombosis?
  • Speaker : J ten Berg (Nieuwegein,NL)

Pro.

Congress : ESC Congress 2013

  • Session : Drop the Aspirin.
  • Speaker : J ten Berg (Nieuwegein,NL)

Pro.

Congress : ESC Congress 2013

  • Session : Drop the Aspirin.
  • Speaker : J ten Berg (Nieuwegein,NL)

Members get more

Join now
  • 1ESC Professional Members – access all resources from ESC Congress and ESC Asia with APSC & AFC
  • 2ESC Association Members (Ivory, Silver, Gold) – access your Association’s congress resources
  • 3Under 40 or in training - with a Combined Membership, access resources from all congresses
Join now

Our sponsors

ESC 365 is supported by Bayer, Boehringer Ingelheim and Lilly Alliance, Bristol-Myers Squibb and Pfizer Alliance, Novartis Pharma AG and Vifor Pharma in the form of educational grants. The sponsors were not involved in the development of this platform and had no influence on its content.

logo esc

Our mission: To reduce the burden of cardiovascular disease

Who we are